Part 1 Blinded - AL001

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)NCT04374136ALECPhase 3Terminated2025-09-01Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.